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Suominen V., Uurto I., Saarinen J., Venermo M., Salenius J. Eur J Vasc
Endovasc Surg 2010;39:316-22.
Objective: This study aims to evaluate mortality across ankle–brachial
index (ABI) values and to assess the association between elevated ABI,
peripheral arterial disease (PAD) and mortality.
Design: This is a retrospective clinical study.
Material and methods: A total of 2159 patients referred with a
suspicion of PAD had their ABI and toe brachial index (TBI) measured by
photoplethysmography. ABI1.3 was considered falsely elevated while TBI
0.60 was the diagnostic criterion for PAD among the subjects. The cohort
was followed up for total and cardiovascular mortality until 30 June 2008, by
record linkage with the National Causes-of-Death Register.
Results: The average follow-up time was 39 months. A total of 576
(26.7%) patients died during the follow-up. Mortality was highest in the
elevated ABI group (35.7% for elevated ABI; 30.1% for low ABI and 16.0%
for normal ABI, p  0.001). There was a greater than twofold risk of total,
and an increased but statistically non-significant risk of, cardiovascular
mortality among patients with elevated ABI. Similar risk ratios were noted
for the low ABI (0.9) group. More pronounced associations were ob-
served at both ends of the scale when ABI was divided into sub-categories.
The overall survival was significantly worse for the elevated ABI group than
for both the normal and the low-ABI group (p  0.01 and p  0.013,
respectively). PADwas found to be independently associated with both total
and cardiovascular mortality among those with elevated ABI (odds ratio
(OR): 2.21; 95% confidence interval (CI): 1.01–4.85 and OR: 4.90; 95%
CI: 1.50–16.04, respectively).
Conclusions: The association between elevated ABI and poor survival
is similar to that of low ABI. PAD appears to be an independent risk factor
for mortality among patients with elevated ABI.
Surgical Techniques to Improve Cannulation ofHemodialysis Vascular
Access
Tordoir J.H.M., van Loon M.M., Peppelenbosch N., Bode A.S., Poeze M.,
van der Sande F.M. Eur J Vasc Endovasc Surg 2010;39:333-9.
Objective: Successful access cannulation is of utmost importance for
adequate hemodialysis treatment. Upper arm fistulae, obesity and deep or
tortuous veins may impair needling and can cause significant complicationsReaders can access EJVES articles at http://intl.eirreversible access loss. Surgical access revision may enhance successful
cannulation.
Methods: A systematic literature review of all publications related to
hemodialysis vascular access, cannulation complications and treatment was
performed.
Results: A total of 384 publications were identified, of which only 17
were related to treatment of cannulation complications in large patient
populations. The clinical success rate of surgical intervention with vein
elevation or transposition ranges from 85% to 91%. The 1-year primary and
secondary patencies are 60% and 71%, respectively. Lipectomy results in an
initial success rate of 100% with a primary and secondary patency of 71% and
98%, respectively, after 1 year of follow-up.
Conclusion: Surgical revision to improve hemodialysis vascular access
cannulation has a high clinical success rate with good long-term patency.
Longterm Results After Surgical Thrombectomy and Simultaneous
Stenting for Symptomatic Iliofemoral Venous Thrombosis
Hölper P., Kotelis D., Attigah N., Hyhlik-Dürr A., Böckler D. Eur J Vasc
Endovasc Surg 2010;39:349-55.
Objectives: To evaluate the longterm outcome of venous thrombec-
tomy and simultaneous stenting in patients with acute, symptomatic iliofem-
oral deep venous thrombosis (DVT).
Methods: Between January 1996 and December 2007, a total of 45
patients underwent venous thrombectomy at our institution. Thrombec-
tomy results were classified by intraoperative phlebography as: TYPE
I  complete, TYPE II  partial, TYPE III  complete with stenosis other
than thrombus, TYPE IV  permanent occlusion. TYPEs I and IV were
excluded from this analysis because no endovascular repair was performed.
25 patients underwent a venous hybrid operation comprising balloon-
catheter thrombectomy, thrombolysis and stenting of residual stensosis.
Three TYPE 2 and 22 TYPE 3 lesions were diagnosed. Three patients died
during follow-up from causes unrelated to their treatment. Three were lost
to follow-up. Hence, 19 patients were examined. A retrospective, non
comparative single-centre study was performed.
Results:Median follow-up was 68months (range 3–129). Primary and
secondary patency rates were 74% (14/19) and 84% (16/19), respectively.
Re-thrombosis occurred within seven days of operation in 26% (5/19).
Procedure related mortality was zero. There was no case of late re-throm-
bosis. Four patients showed post-thrombotic sequelae (CEAP: C1, 2 or 3 s).
No leg ulcer developed in any patient.
Conclusion: Venous thrombectomy with simultaneous stenting re-
and inconvenience for the patient. In the ultimate case, cannulation prob-
lems lead to temporary central vein catheter use for dialysis or even to
sults in excellent longterm results in selected patients with symptomatic
iliofemoral venous thrombosis.lsevierhealth.com/journals/ejvs/default.cfm
